Dr. Kwak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit St Yaw 7
Hematology/Oncology
Boston, MA 02114Phone+1 617-726-6254Fax+1 617-724-6919- Is this information wrong?
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2003
- Duke University School of MedicineClass of 1996
Certifications & Licensure
- MA State Medical License 2001 - 2017
Clinical Trials
- Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer Start of enrollment: 2007 Nov 01
- Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer Start of enrollment: 2007 Oct 01
- Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer Start of enrollment: 2007 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 61 citationsPhase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies.Patrick Schöffski, Daniel S W Tan, Miguel Martín, María Ochoa-de-Olza, John Sarantopoulos, Richard D Carvajal, Chrisann Kyi, Taito Esaki, Amy Prawira, Wallace Akerley,...> ;Journal for Immunotherapy of Cancer. 2022 Feb 1
- 1 citationsRevisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric Cancers.Surendra Pal Chaudhary, Eunice L. Kwak, Katie L. Hwang, Jochen K. Lennerz, Ryan B. Corcoran, Rebecca S. Heist, Andrea L. Russo, Aparna Raj Parikh, Darrell R. Borger, L...> ;The Oncologist. 2020 Nov 1
- 12 citationsA phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancerLipika Goyal, Surendra Pal Chaudhary, Eunice L. Kwak, Thomas A. Abrams, Amanda Carpenter, Brian M. Wolpin, Raymond C. Wadlow, Jill N. Allen, Rebecca S. Heist, Nadine J...> ;Investigational New Drugs. 2020 Jan 2
- Join now to see all
Journal Articles
- Phase 1 Study of AMG 337, a Highly Selective Small-Molecule MET Inhibitor, in Patients with Advanced Solid TumorsEunice L Kwak, Filip Janku, David S Hong, Clinical Cancer Research
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: